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In this issue of Cell Stem Cell, Fasano et al. (2007) investigate the role of Bmi-1 in neural stem cells
in vitro and in vivo. They find a progressively increasing requirement for Bmi-1 function in stem cells
during development that, surprisingly, seems to involve regulation of the cell-cycle inhibitor p21.If stem cells didn’t exist, we would
have to invent them. But how? We
would invent a class of proteins that
would prevent any ‘‘major’’ change in
the state of the cells as they divide.
That sounds simple, but in fact it’s
very hard to stop epigenetic modifica-
tion in its tracks. It’s like being halfway
down a double black diamond ski
slope: you must ski.
In Fasano et al., we learn that the
polycomb gene Bmi-1 first has effects
on stem cell maintenance during mid-
gestation brain development but then
has a progressively more important
role as development proceeds (Fa-
sano et al., 2007). So, in effect, Bmi-1
expression may limit the severity of
the slope that the stem cells have to
navigate. Bmi-1 is a polycomb gene
that sustains stem cells in postnatal
life. It is the mouse homolog of the fly
gene posterior sex combs (Psc) and
is a central component of polycomb
repressor complex 2 (PRC2) that
maintains chromatin in the repressed
or inactive state. Null mutant mice
show transformation of skeletal struc-
tures to more posterior identities (van
der Lugt et al., 1994). Bmi-1/ ani-
mals are born but show a decrease in
the number of hematopoietic stemcells (HSCs) that becomes worse
with age, and the HSCs they do have
show suboptimal proliferative re-
sponses. The initially reported neuro-
logical abnormalities have been pur-
sued in studies showing that
expansion of neurospheres is compro-
mised in cells derived from late stages
of neural development (Molofsky et al.,
2003). Now, Fasano and colleagues
have used acute shRNA-mediated
knockdown to investigate the role of
Bmi-1 in a temporally regulated way.
They found that loss of Bmi-1 leads
to impaired neural stem cell prolifera-
tion, and that the strength of the effect
increases during the course of devel-
opment.
Bmi-1 was discovered as an onco-
gene, and an important paper sug-
gested that its oncogenic function is
mediated by inhibition of the Ink4a/
ARF locus (Jacobs et al., 1999). This
locus codes for two tumor suppres-
sors that act through p53 and Rb to
regulate cell-cycle progression, and
this pathway is now accepted as the
oncogenic mechanism of Bmi-1. Pre-
vious studies have implicated
p16Ink4a in mediating the effects of
Bmi-1 loss in neural stem cells (Molof-
sky et al., 2003). A reasonable predic-Cell Stemtion, therefore, would have been that
the reduced proliferation seen by Fa-
sano et al. after acute Bmi-1 knock-
down is also mediated by Ink4a/ARF.
However, instead the authors saw up-
regulation of a different cell-cycle in-
hibitor, p21. Functional experiments
confirmed that reduction of p21 ex-
pression, but not of Ink4a/ARF, res-
cued the effect of losing Bmi-1. Thus,
their studies suggest that p21 rather
than Ink4a/ARF expression is the im-
mediate target of Bmi-1 in the devel-
oping CNS. Fasano et al. also noted
upregulation of other p21-Rb pathway
components in a stage-specific man-
ner. An important caveat is that the
shRNA method used could leave suffi-
cient residual expression of Ink4a/ARF
to mask a functional role in this
context. Nevertheless, this result is
important because it provides a new
molecular target to help define
the mechanisms that control progres-
sive change in stem cells during
development.
Loss of p21 or p53 leads to a long-
term loss of stem cells in the CNS
that is thought to be a consequence
of overproliferation and subsequent
exhaustion of the stem cell reservoir
(Meletis et al., 2006; Kippin et al.,Cell 1, July 2007 ª2007 Elsevier Inc. 15
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Previews2005). When N-Myc is deleted in the
developing brain, p21 expression is
elevated and progenitor proliferation is
reduced (Knoepfler et al., 2002). p21
also limits the proliferation of precur-
sors in the adult brain in response to
ischemic injury (Qiu et al., 2004). All
these data are consistent with Bmi-1
playing an important and ongoing
role in the regulation of p21 in neural
stem cells. There is also good evi-
dence that Ink4a plays a role in the
aging of HSCs, pancreatic islets, and
the forebrain. It remains possible that
p21 upregulation induces subsequent
expression of Ink4a/ARF, and it is
also possible that there are other cell-
cycle inhibitors regulated by Bmi-1.
Mel18 is another polycomb gene
closely related to Bmi-1. Mel18/
mice die when they are 1 month old
and also show posterior skeletal trans-
formations. Mice lacking both the
Mel18 and Bmi-1 genes die after em-
bryonic day 9.5 (Akasaka et al.,
2001), suggesting that they have re-
lated roles. ES cells, however, do not16 Cell Stem Cell 1, July 2007 ª2007 Elsrequire Bmi-1 and are insensitive to
Ink4a (Burdon et al., 2002). It would
be interesting to test the acute require-
ments for Mel18 in neural stem cell
proliferation and maintenance directly
at different embryonic stages. An in-
triguing possibility is that Bmi-1 and
Mel18 cooperate in the mechanisms
controlling stem cell maintenance.
Perhaps the Mel18/Bmi-1 ratio could
evenmeasure how far down the epige-
netic slope the cell has moved.
A more detailed understanding of
these mechanisms will explain how
the final descent of the epigenetic
mountain occurs in stem cells as they
lose their self-renewal capacity. In the
long run, it could suggest strategies
to delay the inevitable stem cell senes-
cence and tissue aging ‘‘white-out’’
that lies at the end of the epigenetic
ski run.
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